average weight loss per month on tirzepatide How Much Will I Lose Tirzepatide? Clinical Data & Expectations Adults with obesity using tirzepatide

, The most recent published research (January 2025), a large nationwide case-time-control study using data in France, found no evidence that GLP-1 use increased short-term risk of suicide or suicide attempt in patients with obesity or history of psychiatric disorders

If still below 70 mg/dL, repeat treatment

Research & Development (R&D) This initial stage involves discovering and developing GLP-1 peptide molecules with the potential for effective weight loss

For more information on our services and to explore other wellness options, please visit our website or contact us directly

If you are considering tirzepatide as part of your weight management strategy, we invite you to consult with us

any changes should be made only under clinical guidance